Login / Signup

Changing amyotrophic lateral sclerosis diagnostic criteria: Will it impact clinical trials?

Jeremy M Shefner
Published in: Muscle & nerve (2022)
Keyphrases
  • amyotrophic lateral sclerosis
  • clinical trial
  • phase ii
  • randomized controlled trial
  • open label
  • study protocol
  • double blind
  • placebo controlled